List of products in the National Drug Code with proprietary name . This medication is used to treat bladder cancer. Erdafitinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells that have a certain type of abnormal gene ("FGFR").
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
70225-1113 | Erdafitinib | Powder | Natco Pharma Limited | Bulk Ingredient |